ROSSARI BIOTECH LIMITED — Call Transcript 2020

Aug 19, 2020

==> picture [117 x 25] intentionally omitted <==

==> picture [94 x 47] intentionally omitted <==

==> picture [68 x 52] intentionally omitted <==

==> picture [110 x 29] intentionally omitted <==

Axis House, C-2, Wadia International Centre, P.B Marg. Worli, Mumbai 400 025 (India)

Rossari Biotech Ltd

Q1FY21 Earnings Call on August 24[th] 2020 hosted by Axis Capital Limited

We are pleased to host post results earnings conference call for analysts and investors , on Monday, August 24[th] 2020 at 4:00 pm, on behalf of Rossari Biotech Ltd, following the announcement of financial results for the quarter ended 30[th] June 2020.

The call will be initiated with a brief management discussion on the Q1FY21 earnings performance followed by an interactive Question & Answer session. The management team will be represented by

• Mr. Edward Menezes , Promoter & Executive Chairman

• Mr. Sunil Chari , Promoter & Managing Director

• Ms. Manasi Nisal , Chief Financial Officer

Details of the conference call are:

Details of the conference	call are:
Date :	Monday, 24th August, 2020
Time :	4:00 PM IST	6:30 PM HK/SG
Call Leader :	Ankur Periwal, Axis Capital Ltd
Country	Dial in numbers
Primarynumber	+91 22 6280 1145
Secondary number	+91 22 7115 8046
India Local	+91 70456 71221
International Dial In
- Hong Kong	800 964 448
- Singapore	800 101 2045
- U K	0 808 101 1573
- USA	1 866 746 2133

Or please use the under mentioned Diamond Pass link to pre-register for the earnings call and avoid que: https://services.choruscall.in/DiamondPassRegistration/register?confirmationNumber=6819154&linkSecurityString=124 6aef21e

For further information please contact

Ankur Periwal, CFA, FRM SVP – Specialty Chemicals & Midcaps Axis Capital Limited Direct: +91 22 4325 1118 Mobile: +91 98204 16359 Email: ankur.periwal@axiscap.in